Multiple pharmacokinetic parameter prediction for a series of cephalosporins.

The goal of quantitative structure-pharmacokinetic relationship analyses is to develop useful models that can predict one or more pharmacokinetic properties of a particular compound. In the present study, a multiple-output artificial neural network model was constructed to predict human half-life, renal and total body clearance, fraction excreted in urine, volume of distribution, and fraction bound to plasma proteins for a series of cephalosporins. Descriptors generated solely from drug structure were used as inputs for the model, and the six pharmacokinetic parameters were simultaneously predicted as outputs. The final 10 descriptor model contained sufficient information for successful predictions using both internal and external test compounds. Descriptors were found to contribute to individual pharmacokinetic parameters to differing extents, such that descriptor importance was independent of the relationships between pharmacokinetic parameters. This technique provides the advantage of simultaneous prediction of multiple parameters using information obtained by nonexperimental means, with the potential for use during the early stages of drug development.

[1]  H. Black,et al.  A comprehensive review of the clinical pharmacology and pharmacokinetics of cefaclor. , 1988, Clinical Therapeutics.

[2]  K Krishnan,et al.  Quantitative structure-pharmacokinetic relationship modelling. , 2001, The Science of the total environment.

[3]  R. Quintiliani,et al.  Clinical Pharmacokinetics of Ceftriaxone , 1989, Clinical pharmacokinetics.

[4]  P. Hinderling,et al.  Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man , 1984, Journal of Pharmacokinetics and Biopharmaceutics.

[5]  L. Wiseman,et al.  Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential. , 1993, Drugs.

[6]  Anthony Long,et al.  Computer systems for the prediction of xenobiotic metabolism. , 2002, Advanced drug delivery reviews.

[7]  Jorge Gálvez,et al.  Charge Indexes. New Topological Descriptors , 1994, J. Chem. Inf. Comput. Sci..

[8]  M Danhof,et al.  Multivariate quantitative structure-pharmacokinetic relationships (QSPKR) analysis of adenosine A1 receptor agonists in rat. , 1999, Journal of pharmaceutical sciences.

[9]  M. Hosseini,et al.  Using Artificial Neural Networks To Classify the Activity of Capsaicin and Its Analogues , 1997, J. Chem. Inf. Comput. Sci..

[10]  M. Dudley,et al.  Review of cefonicid, a long-acting cephalosporin. , 1984, Clinical Pharmacist.

[11]  S Agatonovic-Kustrin,et al.  Theoretically-derived molecular descriptors important in human intestinal absorption. , 2001, Journal of pharmaceutical and biomedical analysis.

[12]  W. Shelver,et al.  Quantitative structure-pharmacokinetic relationships (QSPR) of beta blockers derived using neural networks. , 1995, Journal of pharmaceutical sciences.

[13]  T. Bergan Comparative pharmacokinetics of cefazolin, cephalothin, cephacetril, and cephapirine after intravenous administration. , 1977, Chemotherapy.

[14]  L. Benet,et al.  Pharmacokinetics of cefamandole using a HPLC assay , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[15]  P. Veng‐Pedersen,et al.  Quantitative structure-pharmacokinetic relationships for systemic drug distribution kinetics not confined to a congeneric series. , 1994, Journal of pharmaceutical sciences.

[16]  P. Godley,et al.  Cefpodoxime Proxetil: A New, Broad-Spectrum, Oral Cephalosporin , 1993, The Annals of pharmacotherapy.

[17]  G. Grass,et al.  Physiologically-based pharmacokinetic simulation modelling. , 2002, Advanced drug delivery reviews.

[18]  M. Reinhard,et al.  Handbook for estimating physicochemical properties of organic compounds , 1999 .

[19]  Patrick Poulin,et al.  Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition. , 2002, Journal of pharmaceutical sciences.

[20]  J. Hamilton-miller,et al.  Cefaclor into the millennium. , 1999, Journal of chemotherapy.

[21]  D. Spyker,et al.  Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects , 1981, Antimicrobial Agents and Chemotherapy.

[22]  J. Flaherty,et al.  Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure , 1989, Clinical pharmacology and therapeutics.

[23]  Lotfi A. Zadeh,et al.  The Roles of Fuzzy Logic and Soft Computing in the Conception, Design and Deployment of Intelligent Systems , 1997, Software Agents and Soft Computing.

[24]  L. Thomachot,et al.  Clinical Pharmacokinetics of Cefotetan , 1994, Clinical pharmacokinetics.

[25]  F. Aoki,et al.  Pharmacokinetic Disposition of Loracarbef in Healthy Young Men and Women at Steady State , 1994, Journal of clinical pharmacology.

[26]  R. N. Brogden,et al.  Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. , 1993, Drugs.

[27]  T. Schwinghammer,et al.  Pharmacokinetics of Cephradine Administered Intravenously and Orally to Young and Elderly Subjects , 1990, Journal of clinical pharmacology.

[28]  P. Welling,et al.  A pharmacokinetic comparison of cephalexin and cefadroxil using HPLC assay procedures. , 1985, Biopharmaceutics & drug disposition.

[29]  J. Gálvez,et al.  Pharmacological distribution diagrams: a tool for de novo drug design. , 1996, Journal of molecular graphics.

[30]  J. Flaherty,et al.  Third-generation cephalosporins: a critical evaluation. , 1984, Clinical pharmacy.

[31]  Jesús Vicente de Julián-Ortiz,et al.  Topological Approach to Drug Design , 1995, J. Chem. Inf. Comput. Sci..

[32]  Malcolm Rowland,et al.  Clinical pharmacokinetics : concepts and applications , 1989 .

[33]  W. Adams,et al.  Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination , 1989, Antimicrobial Agents and Chemotherapy.

[34]  R. N. Brogden,et al.  Cefixime , 1989, Drugs.

[35]  S. Agatonovic-Kustrin,et al.  Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. , 2000, Journal of pharmaceutical and biomedical analysis.

[36]  A Bucinski,et al.  Pharmacological classification of drugs based on neural network processing of molecular modeling data. , 2000, Combinatorial chemistry & high throughput screening.

[37]  D. Spyker,et al.  Pharmacokinetics of Cefaclor and Cephalexin: Dosage Nomograms for Impaired Renal Function , 1978, Antimicrobial Agents and Chemotherapy.

[38]  H. Lode,et al.  Comparative pharmacokinetics of cefoperazone and cefotaxime. , 1980, Clinical therapeutics.